Corporate & Investor Presentation
Big data analysis demonstrates CPAP treatment
decreases mortality rates by 39%
Objective: to investigate the effects of CPAP therapy use on all-cause mortality in patients with OSA
ALASKA study¹ conducted using data from
SNDS, one of the largest anonymized claims
databases in the world representing over 99% of
the French population
-
―
Included >176,000 people in France
New CPAP users aged 18+, initiated
treatment Jan'15-Dec'16
Survival probability
1.00
0.98
0.96
0.94
CPAP therapy termination
CPAP therapy continuation
.
OSA patients who continued CPAP therapy over
the 3-year study period were 39% more likely to
survive than those who discontinued CPAP
therapy
1.
Pepin, et al. ERJ suppl (ERS) 2021
HR 0.61, 95% confidence interval [CI] 0.57-0.65;
Log-rank p<0.01
0
0
1
2
3
Time [years]
CPAP treatment is a case of life or death
47 2022 ResMed | Corporate & Investor Presentation - updated 27JAN22
ResMedView entire presentation